Clinical Trial Update: First-in-Human Assessment of Safety, Biodistribution and Pharmacokinetics of 18F-Fluoro-1-Naphthol (18F-4FN) for PET Imaging [Phase 1]

View source ↗

Summary

A first-in-human phase 1 trial is evaluating safety, biodistribution, and pharmacokinetics of the PET tracer 18F-4FN. The study targets endocrine neoplasia and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endocrine Neoplasia

Drugs mentioned

• 18F-Fluoro-1-Naphthol (18F-4FN) for PET Imaging (18F-4FN)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Endocrine Neoplasia | Phase 1 | Status: RECRUITING